# US 5,700,657 A · Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,700,657 A
- Document ID: US5700657A
- Status: Granted
- Kind: A
- Application number: 08/166,297
- Filed: 1993-12-13
- Granted: 1997-12-23
- Earliest claimed: 1993-12-13
- Assignees: Genzyme Corporation
- Inventors: Gary A. Beaudry; Arthur H. Bertelsen; Michael I. Sherman; Bert Vogelstein
- Web page: https://patentgrep.com/patent/US5700657A

## CPC

- C07K 14/4746: {p53}
- C12N 2799/027: where the vector is derived from a retrovirus
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Vectors and vector systems are embodied that include a gene encoding a tumor suppressor protein. In one embodiment, the vector includes a gene encoding a tumor suppressor protein and an inducible promoter controlling the gene encoding a tumor suppressor protein. The tumor suppressor protein may be p53 protein. In another embodiment, there is provided a vector system which comprises a first vector including a gene encoding a tumor suppressor protein, and a second vector containing a nucleic acid sequence encoding an antisense sequence complementary to all or a portion of the gene encoding a tumor suppressor protein. In yet another embodiment, there is provided a vector system which comprises a first vector including a gene encoding a tumor suppressor protein, and a second vector containing a gene which encodes a protein which binds to, and thereby inhibits, the tumor suppressor protein. Such vectors and vector systems enable cells transformed thereby to continue to proliferate such that adequate amounts of infectious viral particles, generated from viral vectors including a gene encoding a tumor suppressor protein, can be harvested for administration to patients.

## Claims

### Claim 1

A process for producing a retroviral vector particle in a producer cell comprising:
producing a retroviral vector particle from a producer cell containing a retroviral vector including RNA or DNA encoding a tumor suppressor protein wherein expression of said tumor suppressor protein is controlled by an inducible promoter and said retroviral vector particle is produced under conditions under which the inducible promoter is not activated.

### Claim 2 (depends on 1)

The process of claim 1 wherein said tumor suppressor protein is selected from the group consisting of p53 protein; DCC protein; APC protein, MCC protein; WT1 protein; NF1 protein; and NF2 protein; and von Hippel-Lindau disease protein.

### Claim 3 (depends on 1)

The process of claim 1 wherein said minor suppressor protein is the p53 protein.

### Claim 4 (depends on 3)

The process of claim 3 wherein said inducible promoter is selected form the group consisting of metallothionein promoters, mouse mammary tumor virus promoter, interferon response element-containing promoters, lac operator--containing promoters, heat shock promoters, and hormone-responsive promoters.

### Claim 5 (depends on 4)

The process of claim 4 wherein said promoter is a metallothionein promoter and said producer cells are grown in a medium lacking trace metals.

### Claim 6 (depends on 4)

The process of claim 4 wherein said promoter is a hormone-responsive promoter and said producer cells are grown in a medium lacking said hormone which induces said hormone-responsive promoter.

### Claim 7

A producer cell for producing a retroviral vector particle, said producer cell containing DNA or RNA encoding a tumor suppressor protein and an inducible promoter controlling expression of said DNA or RNA encoding said tumor suppressor protein, wherein said tumor suppressor protein is not expressed under the conditions under which the producer cell is maintained.

### Claim 8 (depends on 7)

The producer cell of claim 7 wherein said tumor suppressor protein is p53 protein.